Sector News

ALTANA Management Board Repositions Itself for the Future

June 26, 2015
Chemical Value Chain
The Supervisory Board of the specialty chemicals company ALTANA has appointed Martin Babilas (43) to become the Chief Executive Officer. On January 1, 2016, he will succeed Dr. Matthias L. Wolfgruber (61), who will retire. Martin Babilas has been the Chief Financial Officer of ALTANA AG since 2007. In November of last year, he took over additional responsibility of two of the company’s four divisions from Dr. Wolfgruber. Babilas has worked for ALTANA since 1998.
 
“The generation change in the company’s management reflects sustainable corporate development, as well as the Group’s ability to change,” said Dr. Klaus-Jurgen Schmieder, Chairman of the Supervisory Board of ALTANA AG. “Under the leadership of Dr. Wolfgruber, ALTANA’s chemical business has developed extraordinarily successfully in the last 13 years while undergoing constant changes. We would like to express our sincere gratitude and great appreciation for him already today. As a longtime member of the Management Board, Martin Babilas has played a key role in the development of ALTANA’s strategy. We are convinced that he will continue to lead the company on this successful path.”
 
The Supervisory Board has appointed Stefan Genten (46) as ALTANA’s new Chief Financial Officer as of August 1, 2015. Stefan Genten worked in various management capacities for the Grunenthal pharmaceutical group for 13 years, since 2005 as a member of the Corporate Executive Board and as the CFO. He was also in charge of operative functions, for example for the Latin American business, and as Group Chief Operating Officer (COO) for the last five years.
 
“We are pleased to have attracted Stefan Genten, a proven leadership personality, to ALTANA,” said Dr. Schmieder about the new CFO. “He will provide us with new impetus and we will benefit from his many years of international experience.”
 
On January 1, 2016, Martin Babilas will take over responsibility for Corporate Development/M&A, Human Resources, Corporate Communications and Internal Audit from Dr. Wolfgruber. On that same date, Dr. Christoph Schlunken (53) will assume responsibility for Innovation Management. Dr. Schlunken became a third member of ALTANA’s Management Board last November.
 
Source: ALTANA

Related News

April 17, 2021

Veolia agrees deal for Suez, merging world’s largest water firms

Chemical Value Chain

VEOLIA has agreed a deal to buy its rival Suez, ending a fraught takeover battle that merges the world’s two largest water and wastewater companies.

April 17, 2021

Borealis begins feasibility study for new chemical-recycling plant in Sweden 

Chemical Value Chain

Borealis Group AG has commenced a new project to secure an increased supply of chemically recycled feedstock for the production of more circular base chemicals and polyolefin-based products.

April 17, 2021

Novozymes joins call to the Biden Administration for significant action in the U.S. to mitigate climate change.

Chemical Value Chain

The call is part of a campaign by Ceres, a nonprofit organization transforming the economy, and the We Mean Business coalition – a global, nonprofit coalition that collaborates with progressive businesses, to bolster action on climate change towards a zero-carbon economy.

Send this to a friend